UBS Group’s Kiora Pharmaceuticals KPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50.8K Buy
17,644
+17,642
+882,100% +$50.8K ﹤0.01% 6471
2025
Q1
$6 Hold
2
﹤0.01% 8817
2024
Q4
$7 Sell
2
-352
-99% -$1.23K ﹤0.01% 8574
2024
Q3
$1.3K Sell
354
-7,966
-96% -$29.1K ﹤0.01% 7451
2024
Q2
$34.9K Buy
+8,320
New +$34.9K ﹤0.01% 5815
2024
Q1
Sell
-246
Closed -$1.15K 8401
2023
Q4
$1.15K Buy
246
+83
+51% +$389 ﹤0.01% 7176
2023
Q3
$834 Buy
163
+162
+16,200% +$829 ﹤0.01% 7104
2023
Q2
$5 Sell
1
-17
-94% -$85 ﹤0.01% 7681
2023
Q1
$555 Sell
18
-455
-96% -$14K ﹤0.01% 7875
2022
Q4
$14.6K Buy
473
+235
+99% +$7.25K ﹤0.01% 6874
2022
Q3
$13K Buy
238
+158
+198% +$8.63K ﹤0.01% 6943
2022
Q2
$13K Buy
80
+79
+7,900% +$12.8K ﹤0.01% 6477
2022
Q1
$0 Sell
1
-56
-98% ﹤0.01% 9395
2021
Q4
$31K Buy
57
+56
+5,600% +$30.5K ﹤0.01% 6254
2021
Q3
$1K Hold
1
﹤0.01% 8044
2021
Q2
$1K Sell
1
-11
-92% -$11K ﹤0.01% 8044
2021
Q1
$21K Buy
12
+1
+9% +$1.75K ﹤0.01% 6315
2020
Q4
$20K Buy
11
+10
+1,000% +$18.2K ﹤0.01% 5930
2020
Q3
$2K Sell
1
-6
-86% -$12K ﹤0.01% 6780
2020
Q2
$12K Buy
7
+3
+75% +$5.14K ﹤0.01% 6037
2020
Q1
$7K Buy
4
+2
+100% +$3.5K ﹤0.01% 6226
2019
Q4
$6K Buy
2
+1
+100% +$3K ﹤0.01% 6438
2019
Q3
$2K Sell
1
-10
-91% -$20K ﹤0.01% 6763
2019
Q2
$14K Buy
11
+10
+1,000% +$12.7K ﹤0.01% 5967
2019
Q1
$2K Sell
1
-4
-80% -$8K ﹤0.01% 6610
2018
Q4
$13K Buy
5
+4
+400% +$10.4K ﹤0.01% 6169
2018
Q3
$1K Sell
1
-2
-67% -$2K ﹤0.01% 6903
2018
Q2
$8K Buy
+3
New +$8K ﹤0.01% 6335
2018
Q1
Sell
-1
Closed -$5K 6742
2017
Q4
$5K Buy
+1
New +$5K ﹤0.01% 6399
2017
Q1
Hold
0
-$4K 6741
2016
Q4
Hold
0
6340
2016
Q3
Sell
-1
Closed -$8K 6772
2016
Q2
$8K Buy
+1
New +$8K ﹤0.01% 6003
2016
Q1
Hold
0
-$4K 6430
2015
Q4
Sell
-1
Closed -$11K 6388
2015
Q3
$11K Buy
+1
New +$11K ﹤0.01% 5867